Chemistry: analytical and immunological testing – Lipids – triglycerides – cholesterol – or lipoproteins
Reexamination Certificate
2005-09-16
2009-02-17
Kam, Chih-Min (Department: 1656)
Chemistry: analytical and immunological testing
Lipids, triglycerides, cholesterol, or lipoproteins
C530S359000
Reexamination Certificate
active
07491543
ABSTRACT:
This invention provides methods of using of the sizes and levels of high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particles, the -641 allele of the promoter of the gene encoding apolipoprotein C-3 (APOC-3), the 405 allele of the gene encoding cholesteryl ester transfer protein (CETP), and plasma levels of insulin-like growth factor-1 (IGF-1), adiponectin, CETP and APOC-3, for determining and increasing an individual's likelihood of longevity and of retaining cognitive function during aging, and for determining and decreasing an individual's likelihood of developing a cardiovascular-, metabolic- or age-related disease.
REFERENCES:
Arai Y et al., entitled “Deficiency of choresteryl ester transfer protein and gene polymorphisms of lipoprotein lipase and hepatic lipase are not associated with longevity,” J Mol Med (2003) 81:102-109.
Olivieri O et al., entitled “ApoC-III gene polymorphisms and risk of coronary artery disease,” Journal of Lipid Research, vol. 43, 2002, 1450-1457.
Holmes M D et al., entitled “Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations,” Cancer Epidemiology Biomakers & Prevention, vol. 11, Sep. 2002, 862-867.
Lamarche B et al., entitled “The small dense LDL phenotype and the risk of cornary heart disease: Epidemiology, Path-Physiology and Therapeutic Aspects,” Diabetes & Metabolism (Paris), vol. 25, 1999, 199-211.
Anber, V et al., entitled “Interaction of Very-Low-Density, Intermediate-Density, and Low-Density Lipoproteins With Human Arterial Wall Proteoglycans,” Arterioscler Thromb Vasc Biol. 1997;17:2507-2514.
Arai, Y et al., entitled “Lipid and Lipoprotein Profile of Japanese Centenarians-Hige Prevalence of Hypo Beta Lipoproteinemia,” Nippon Ronen Igakkai Zasshi, Jpn J Geriat 1997; 34:202-208.
Arai, T et al., entitled “Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency,” Clinica Chimic Acta 301 (2000) 103-117.
Austin, M A, entitled “Triglyceride, Small, Dense Low-density Lipoprotein, and the Atherogenic Lipoprotein Phenotype,” Current Atherosclerosis Reports 2000, 2:200-207.
Atzmon, G et al., entitled “Plasma HDL Levels Highly Correlate With Cognitive Function in Exceptional Longevity,” Journal of Gerontology: Medical Sciences, 2002, vol. 57A, No. 11, M712-M715.
Atzmon, G et al., entitled “Clinical Phenotype of Families with Longevity,” J Am Geriatr Soc 52:274-277, 2004.
Atzmon, G et al., entitled “Biological evidence for inheritance of exceptional longevity,” Mechanisms of Ageing and Development 126 (2005), 341-345.
Barzilai, N et al., entitled “Einstein's institute for aging research: collaborative and programmatic approaches in the search for successful aging,” Experimental Gerontology 39 (2004) 151-157.
Barzilai, N et al., entitled “Offspring of Centenarians Have a Favorable Lipid Profile,” J Am Geriatr Soc 49:76-79, 2001.
Barzilai, N entitled “Discovering the Secrets of Successful Longevity,” Journal of Gerontology: Medical Sciences 2003, vol. 58A, No. 3, 225-226.
Barzilai, N et al., entitled “Searching for Human Longevity Genes: The Future History of Gerontology in the Post-genomic Era,” Journal of Gerontology: Medical Sciences, 2001, vol. 56A, No. 2, M83-M87.
Barzilai, N et al., entitled “Unique Lipoprotein Phenotype and Genotype Associated with Exceptional Longevity,” JAMA, Oct. 15, 2003, vol. 290, No. 15, 2030-2040.
Barbagallo, C M et al., entitled “Liporprotein Profile and High-Density Lipoproteins: Subfractions Distribution in Centenarians,” Gerontology 1998;44:106-110.
Bjornheden, T et al., entitled “Accumuation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system,” Atherosclerosis 123 (1996) 43-56.
Blake, G J et al., entitled “Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women,”Circulation, 2002;106:1930-1937.
Campos, H et al., entitled “LDL Particle Size Distribution: Results from the Framingham Offspring Study,” Arteriosclerosis and Thrombosis 1992;12:1410-1419.
Chait, A et al., entitled “Susceptibility of Small, Dense, Low-Density Lipoproteins to Oxidative Modification in Subjects with the Atherogenic Lipoprotein Phenotype, Pattern B,” The American Journal of Medicine, Apr. 1993, vol. 94, 350-356.
Ettinger, W H. et al., entitled “High Density Lipoprotein Cholesterol Subfractions in Older People,” Journal of Gerontology: Medical Sciences 1994, vol. 49, No. 3, M116-M122.
Evert, J et al., entitled “Mobidity Profiles of Centenarians: Survivors, Delayers, and Escapers,” Journal of Gerontology: Medical Sciences, 2003, vol. 58A, No. 3, 232-237.
Ferrara, A et al., entitled “Total, LDL, and HDL Cholesterol Decrease With Age in Older Men and Women: The Rancho Bernardo Study 1984-1994,” Circulation, 1997;96:37-43.
Gardner, C D et al., entitled “Association of Small Low-Density Lipoprotein Particles with the Incidence of Coronary Artery Disease in Men and Women,” JAMA, Sep. 18, 1996, vol. 276, No. 11, 875-881.
Kamigaki, A S et al., entitled “Low Density Lipoprotein Particle Size and Risk of Early-Onset Myocardial infarction in Women,” American Journal of Epidemiology, 2001, vol. 153, No. 10, 939-945.
Lamarche, B et al., entitled “Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men: Prospective Results from the Quebec Cardiovascular Study,” Circulation, 1997;95:69-75.
Libby, P, entitled “Managing the Risk of Atherosclerosis: The Role of High-Density Lipoprotein,” Am J Cardiol 2001;88(suppl):3N-8N.
Malaguarnera, M et al., entitled “Lipid profile variations in a group of healthy elderly and centenarians,” European Review for Medical and Pharmacological Sciences, 1998;2:75-79.
Merched, A et al., entitled “Decreased high-density lipoprotein cholesterol and serum apolipoprotein Al concentrations are highly correlated with the severity of Alzheimer's disease,” Neurobiology of Aging 21 (2000) 27-30.
Pascot, A et al., entitled “HDL particle size: a marker of the gender difference in the metabolic risk profile,”Atherosclerosis 160 (2002) 399-406.
Perls, T T et al., entitled “Siblings of centenarians live longer,” The Lancet, vol. 351, May 23, 1998, 1560.
Perls, T T et al., entitled “Life-long sustained mortality advantage of siblings of centenarians,” PNAS, Jun. 11, 2002, vol. 99, No. 12, 8442-8447.
Stampfer, M J et al., entitled “A Prospective Study of Triglyceride Level, Low-Density Lipoprotein Particle Diameter, and Risk of Myocardial Infarction,” JAMA, Sep. 18, 1996, vol. 276, No. 11, 882-888.
Superko, R H, entitled “Small, Dense Low-Density Lipoprotein Subclass Pattern B: Issues for the Clinician,” Current Atherosclerosis Reports 1999, 1:50-57.
Vakkilainen, J et al., entitled “Endothelial Dysfunction in Men with Small LDL Particles,” Circulation, 2000, 102:716-721.
Van Exel, E et al., entitled “Association between High-Density Lipoprotein and Cognitive Impairment in the Oldest Old,” Ann Neurol 2002;51:716-721.
Von Eckardstein, A et al., entitled “Physiological role and clinical relevance of high-density lipoprotein subclasses,” Current Opinion in Lipidology 1994, 5:404-416.
Wilson, P W F et al., entitled “Determinants of Change in Total Cholesterol and HDL-C With Age: The Framingham Study,” Journal of Gerontology: Medical Sciences 1994, vol. 49, No. 6, M252-M257.
Yoshida, A et al., entitled “Variability in Cholesteryl Ester Tran
Albert Einstein College of Medicine of Yeshiva University
Amster Rothstein & Ebenstein LLP
Kam Chih-Min
LandOfFree
Biological markers for longevity and diseases and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biological markers for longevity and diseases and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biological markers for longevity and diseases and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4099846